Free Trial

Enovis (ENOV) Competitors

Enovis logo
$33.34 -0.21 (-0.61%)
Closing price 06/11/2025 03:59 PM Eastern
Extended Trading
$34.63 +1.29 (+3.86%)
As of 08:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ENOV vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, INSP, SLNO, PRCT, and NVST

Should you be buying Enovis stock or one of its competitors? The main competitors of Enovis include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

Enovis vs. Its Competitors

Stevanato Group (NYSE:STVN) and Enovis (NYSE:ENOV) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends.

Stevanato Group has a net margin of 10.47% compared to Enovis' net margin of -5.95%. Stevanato Group's return on equity of 9.86% beat Enovis' return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
Enovis -5.95%4.39%2.80%

98.4% of Enovis shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 2.7% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Enovis received 4 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 66.04% of users gave Enovis an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%
EnovisOutperform Votes
35
66.04%
Underperform Votes
18
33.96%

Stevanato Group has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.12B6.67$157.62M$0.5148.57
Enovis$2.15B0.89-$33.26M-$13.95-2.39

Stevanato Group has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500.

In the previous week, Stevanato Group had 1 more articles in the media than Enovis. MarketBeat recorded 5 mentions for Stevanato Group and 4 mentions for Enovis. Stevanato Group's average media sentiment score of 1.14 beat Enovis' score of 0.87 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Enovis
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Enovis has a consensus price target of $58.00, suggesting a potential upside of 73.94%. Given Enovis' higher probable upside, analysts clearly believe Enovis is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
Enovis
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Summary

Stevanato Group beats Enovis on 11 of the 18 factors compared between the two stocks.

Get Enovis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENOV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ENOV vs. The Competition

MetricEnovisSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$1.90B$9.31B$5.57B$19.81B
Dividend YieldN/A1.26%5.28%3.83%
P/E Ratio-15.2321.0327.1435.67
Price / Sales0.8944.12411.9846.74
Price / Cash6.8619.6738.2517.52
Price / Book0.535.227.064.84
Net Income-$33.26M$284.66M$3.23B$1.02B
7 Day Performance5.54%0.83%2.85%1.94%
1 Month Performance-9.07%-4.38%9.06%3.03%
1 Year Performance-26.14%-20.92%31.43%9.73%

Enovis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ENOV
Enovis
2.7567 of 5 stars
$33.34
-0.6%
$58.00
+73.9%
-25.5%$1.90B$2.15B-15.236,800
STVN
Stevanato Group
2.2721 of 5 stars
€22.01
-0.9%
N/A+36.4%$6.67B$1.12B46.834,650Positive News
GKOS
Glaukos
4.4309 of 5 stars
$94.89
+0.6%
$134.67
+41.9%
-12.3%$5.42B$404.52M-33.06780
NARI
Inari Medical
0.5254 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800News Coverage
IRTC
iRhythm Technologies
1.3218 of 5 stars
$140.65
+0.1%
$133.73
-4.9%
+59.0%$4.49B$618.59M-38.641,790Analyst Forecast
TMDX
TransMedics Group
1.3599 of 5 stars
$123.94
-2.5%
$126.70
+2.2%
+2.8%$4.19B$488.23M131.85210
BLCO
Bausch + Lomb
3.9002 of 5 stars
$11.46
-0.1%
$15.50
+35.3%
-16.3%$4.05B$4.83B-12.5912,500Analyst Forecast
INSP
Inspire Medical Systems
4.7896 of 5 stars
$133.66
-3.3%
$211.91
+58.5%
-19.9%$3.94B$840.11M77.26760Positive News
SLNO
Soleno Therapeutics
4.8226 of 5 stars
$75.66
+3.1%
$106.78
+41.1%
+70.5%$3.81BN/A-22.7930Positive News
Analyst Revision
Gap Up
PRCT
PROCEPT BioRobotics
1.9139 of 5 stars
$57.94
-0.1%
$90.00
+55.3%
-7.4%$3.21B$249.12M-29.71430
NVST
Envista
3.4015 of 5 stars
$18.09
-1.0%
$20.23
+11.8%
+5.9%$3.07B$2.50B-2.7912,700

Related Companies and Tools


This page (NYSE:ENOV) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners